An Open-label, Randomized, Fasting, Single-dose, 2-sequence, 2-period, Crossover Phase 1 Study After Administration of HUC2-344 and Co-administration of HUC2-344-R1 and HUC2-344-R2 in Healthy Volunteers
Latest Information Update: 21 Aug 2024
At a glance
- Drugs HUC2 344 (Primary)
- Indications Diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Huons
Most Recent Events
- 21 Aug 2024 New trial record